#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Macular telangiectasia Dementia Alzheimer's type Osteochondrodysplasia Congenital myopathy Pleural mesothelioma malignant Henoch-Schonlein purpura Endocrine ophthalmopathy Idiopathic intracranial hypertension Chronic lymphocytic leukaemia recurrent Marfan's syndrome ABO haemolytic disease of newborn Neuropathy peripheral Skin cancer Palmoplantar pustulosis Brain stem glioma More trials…

    Learn about Rare Diseases

    Haemophilia A with anti factor VIII – Diagnostics Optic glioma – Treatment Acquired haemophilia – Life with Disease Pulmonary sarcoidosis Turner’s syndrome – Basic Information Angiosarcoma recurrent – Life with Disease Rosai-Dorfman syndrome – Treatment Brain stem glioma – Trials in Disease Factor VIII deficiency – Life with Disease Pleomorphic leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Atropine Sulfate Monohydrate TALADEGIB GSKVX000000039711 Ticagrelor Pp1815 Protein C TUB-030 GSK5460025A Piracetam Gskvx000000009151 Levomepromazine Hydrochloride Sebetralstat Allo-647 Vudalimab Dabigatran XYLOMETAZOLINE HYDROCHLORIDE Inotuzumab Ozogamicin Guanabenz Acetate Thiopental Sodium Valproic Acid More therapies…

    Learn about Your Condition

    Micrographic skin surgery Agitation Tachypnoea Pancreatic carcinoma stage IV Malignant oligodendroglioma Heparin resistance Caesarean section Complicated appendicitis Bone marrow disorder Weaning failure Ophthalmoplegia Breast cancer male Neutropenia Fungal infection Myxofibrosarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Exenatide
    • Glibenclamide
    • Potassium Canrenoate
    Greece

  • Study of Intravenous Immunoglobulin Added to Standard Treatment for COVID-19 in Patients with Severely Weakened Immune System Due to B-cell Problems

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Remdesivir
    • Nirmatrelvir
    • Human Normal Immunoglobulin
    Sweden

  • Testing Bacteriophage Cocktail Safety and Effectiveness in Patients with Complicated Infected Wounds Compared to Placebo

    Not yet recruiting

    4 1 1
    Investigated Drugs:
    • Sodium Chloride
    Czechia

  • Study of paracetamol effects on emotions and thinking in healthy adults aged 18 to 30 years

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Paracetamol
    Norway

  • Testing the Immune Response to Trivalent Inactivated Influenza Vaccine in People with Obesity and Type 2 Diabetes

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Influenza
    • Obesity
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED
    • Influenza A/Victoria/4897/2022 Ivr-238 (H1N1), Inactivated
    • Influenza Virus B/Austria/1359417/2021-Like Strain (B/Austria/1359417/2021, Bvr-26)
    Sweden

  • Testing Psilocybin with Therapy for Treatment of Gambling Disorder in Adults with Problem Gambling

    Not yet recruiting

    2 1
    Investigated Drugs:
    • Hypromellose
    • Dry Extract From Psilocybe Cubensis (15-25:1), Extraction Solvent: Methanol
    France
Previous Page
1 … 745 746 747 748 749 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!